Testosterone gel targets ‘male menopause’

Stephen Beard Jun 11, 2007

MARK AUSTIN THOMAS: A small Scottish company is launching a treatment for “male menopause”. British men of a certain age who are balding, irritable and losing interest in sex could find some relief. From London, here’s Stephen Beard.

STEPHEN BEARD: The company, called ProStrakan, is aiming its product squarely at the flagging libido of some middle-aged British men. The company reckons that 12 percent of men over the age of 40 need a testosterone boost. Their symptoms: baldness, weight gain, irritability and impotence.

ProStrakan’s treatment is in the form of a gel. Patients rub it over themselves once a day. The company is forecasting revenues of up to $150 million a year in Britain. And, says Callum Spreng of ProStrakan, it could notch up even bigger sales in the U.S.

CALLUM SPRENG: Well, the U.S. market is significantly more developed than that in Europe and is reckoned to be worth of the order of $500 million.

The company is planning to file for U.S. approval next year — and if successful, would like to launch the product there in 2009.

In London, this is Stephen Beard for Marketplace.

There’s a lot happening in the world.  Through it all, Marketplace is here for you. 

You rely on Marketplace to break down the world’s events and tell you how it affects you in a fact-based, approachable way. We rely on your financial support to keep making that possible. 

Your donation today powers the independent journalism that you rely on. For just $5/month, you can help sustain Marketplace so we can keep reporting on the things that matter to you.